What are West Pharmaceutical Services's profit margins?

West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.

Where do West Pharmaceutical Services's ratios come from?

Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

West Pharmaceutical Services WST Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	143%+1.7pp	141.3%+1.4pp	139.9%+0.7pp	139.2%-0.4pp	139.6%-2.6pp
Operating margin	78.5%+1.2pp	77.3%-0.7pp	78%-0.4pp	78.3%-0.8pp	79.1%-2.8pp
Net margin	65.7%+0.7pp	65%-1.0pp	65.9%-1.1pp	67%-1.8pp	68.8%-3.3pp
EBITDA margin	100.4%+1.2pp	99.2%-0.5pp	99.7%-0.1pp	99.8%-0.3pp	100.1%-2.1pp
Free cash flow margin	53.7%+3.6pp	50%+5.7pp	44.3%+1.4pp	43%-0.8pp	43.7%-2.6pp
Returns
Return on equity	70.6%+1.7pp	68.9%-0.9pp	69.8%-0.8pp	70.6%-2.0pp	72.6%-3.4pp
Return on assets	52.3%+1.1pp	51.2%-0.7pp	51.9%-0.8pp	52.7%-1.6pp	54.2%-2.6pp
Return on invested capital	72.5%+1.4pp	71.1%-1.3pp	72.4%-1.8pp	74.2%-2.9pp	77.1%-5.4pp
Efficiency
Asset turnover	3.2×0.0×	3.2×0.0×	3.1×0.0×	3.1×0.0×	3.2×0.0×
Inventory turnover	18.9×+0.2×	18.6×+0.1×	18.5×+0.1×	18.4×+0.3×	18.1×+0.4×
Liquidity
Current ratio	11.4×-0.1×	11.4×+0.2×	11.2×-0.1×	11.3×+0.4×	10.9×+0.2×
Quick ratio	8.6×0.0×	8.6×+0.2×	8.4×0.0×	8.4×+0.4×	8×+0.1×
Cash ratio	3.8×0.0×	3.8×+0.3×	3.5×0.0×	3.4×+0.1×	3.3×-0.2×
Leverage
Debt-to-equity	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.5×0.0×
Debt-to-assets	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Net debt / EBITDA	-1.6×-0.1×	-1.5×-0.4×	-1.1×-0.2×	-0.9×-0.1×	-0.8×+0.2×
Per Share
Book value per share	$167.42+2.8%	$162.87+4.7%	$155.58+3.0%	$151.05+3.7%	$145.61+0.5%
Valuation
Market capitalization	$72.72B+2.7%	$70.84B-5.3%	$74.77B-3.9%	$77.82B-9.5%	$86.03B-13.0%
Enterprise value	$71.53B+2.5%	$69.75B-5.7%	$73.97B-4.1%	$77.16B-9.7%	$85.44B-12.9%
Price / earnings	144.6×-1.4×	145.9×-8.1×	154×-5.5×	159.5×-13.3×	172.8×-16.5×
Price / sales	23.7×0.0×	23.7×-1.8×	25.4×-1.4×	26.8×-3.0×	29.8×-4.3×
Price / book	23.9×0.0×	23.9×-2.6×	26.5×-1.8×	28.3×-3.9×	32.2×-4.8×
EV / EBITDA	93×-1.1×	94.1×-6.9×	101×-5.5×	106.5×-11.7×	118.2×-14.2×
EV / sales	23.3×0.0×	23.3×-1.8×	25.2×-1.4×	26.6×-3.0×	29.6×-4.3×
Free cash flow yield	9.1%+0.6pp	8.4%+1.2pp	7.2%+0.5pp	6.7%+0.7pp	6%+0.6pp
Earnings yield	11.2%+0.1pp	11%+0.4pp	10.6%+0.3pp	10.3%+0.9pp	9.4%+0.9pp
Dividend yield	1.3%0.0pp	1.4%+0.1pp	1.3%+0.1pp	1.3%+0.1pp	1.1%+0.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about West Pharmaceutical Services.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are West Pharmaceutical Services's profit margins?: West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.
Where do West Pharmaceutical Services's ratios come from?: Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.